List of articles with "Chengdu"

OptiTROP-Lung04 Study

OptiTROP-Lung04 Study

China Chengdu Sacituzumab NSCLC EGFR-TKI
Cultural Tourism in Sichuan

Cultural Tourism in Sichuan

China Chengdu Panda Sichuan Ease Sichuan Tourism
Trastuzumab Botidotin Results

Trastuzumab Botidotin Results

China Chengdu Kelun-Biotech ESMO 2025 Trastuzumab Botidotin
Lung Cancer Breakthrough

Lung Cancer Breakthrough

China Chengdu Lung Cancer sacituzumab tirumotecan ESMO Congress
Sichuan Cultural Tourism

Sichuan Cultural Tourism

China Chengdu Cultural Tourism Chinese Heritage Sichuan Ease
Sichuan Cultural Tourism

Sichuan Cultural Tourism

China Chengdu Sichuan Ease Jiuzhaigou Valley Sichuan Opera
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan

China Chengdu Kelun-Biotech sacituzumab tirumotecan ESMO
Sichuan Tourism Logo Launch

Sichuan Tourism Logo Launch

China Chengdu Sichuan Cultural Tourism PANDAS
Sichuan Tourism Logo

Sichuan Tourism Logo

China Chengdu Panda Sichuan Ease Shu Culture
Trastuzumab Botidotin Approved

Trastuzumab Botidotin Approved

China Chengdu Kelun-Biotech Trastuzumab Botidotin HER2-Positive BC
Innovative Biomimetic Collagen

Innovative Biomimetic Collagen

China Chengdu Kyoto University LivingPhoenix Biomimetic Collagen
iRegene's Phase I Results

iRegene's Phase I Results

China Chengdu Therapeutics NouvNeu001 iRegene
C-Ray and Biokin Milestone

C-Ray and Biokin Milestone

China Chengdu C-Ray Therapeutics Biokin Pharmaceutical [177Lu]-BL-ARC001
Kelun-Biotech's Sac-TMT Approval

Kelun-Biotech's Sac-TMT Approval

China Chengdu Kelun-Biotech TROP2 ADC Sac-TMT
Full-Life Secures Funding

Full-Life Secures Funding

China Chengdu radiopharmaceuticals Full-Life Technologies Junson Capital
Gavin Zheng Appointed Dean

Gavin Zheng Appointed Dean

China Chengdu Hero Esports Gavin Zheng Chengdu Institute
A400/EP0031 NMPA Review

A400/EP0031 NMPA Review

China Chengdu Kelun-Biotech A400/EP0031 RET Inhibitor
Phase 1 NLRP3 Inhibitor Study

Phase 1 NLRP3 Inhibitor Study

China Chengdu BioAge HitGen BGE-102
Biomimetic Collagen Breakthrough

Biomimetic Collagen Breakthrough

China Chengdu LivingPhoenix Biomimetic Collagen POGMENT
Phase III Trial Milestone

Phase III Trial Milestone

China Chengdu C-Ray Therapeutics Mednovo Group Lutetium Oxodotreotide
Yutong's Link+ Launch

Yutong's Link+ Launch

China Chengdu Yutong Bus Link+ IoV Platform
TWG 2025 Highlights

TWG 2025 Highlights

China Friendship Chengdu World Games Chengdu 2025
Keymed's 2025 Results

Keymed's 2025 Results

China Chengdu Keymed Biosciences CMG901 Kang Yue Da
Keymed's 2025 Results

Keymed's 2025 Results

China Chengdu Stapokibart Keymed R&D Progress
Keymed's 2025 Results

Keymed's 2025 Results

China Chengdu Keymed Biosciences Stapokibart CMG901
HitGen OpenDEL 5.0

HitGen OpenDEL 5.0

China Chengdu Drug Discovery HitGen OpenDEL™
Keymed Strong Results

Keymed Strong Results

China Chengdu AstraZeneca Keymed Biosciences Stapokibart
Keymed's 2025 Interim Success

Keymed's 2025 Interim Success

China Chengdu AstraZeneca Keymed Biosciences Stapokibart
The Shudao Journey

The Shudao Journey

China Chengdu Sichuan Shudao Road Guangyuan
TWG 2025 Farewell

TWG 2025 Farewell

China Friendship Chengdu World Games 2025
NSCLC Therapy Breakthrough

NSCLC Therapy Breakthrough

China Chengdu Sacituzumab NSCLC Tagitanlimab
Kelun-Biotech 2025 Results

Kelun-Biotech 2025 Results

China Chengdu oncology Kelun-Biotech Sacituzumab
Kelun-Biotech & Windward Bio

Kelun-Biotech & Windward Bio

China Chengdu Kelun-Biotech Windward Bio SKB378
BGM's Financial Update

BGM's Financial Update

China biopharmaceuticals BGM Group Chengdu AI Technology
OPENFREE Earbuds Launch

OPENFREE Earbuds Launch

China Chengdu Wireless Earbuds ROSESELSA OPENFREE
HitGen Sustainability Report

HitGen Sustainability Report

Sustainability China Chengdu ESG Practices HitGen Inc.
CATL's Carbon Neutral Vision

CATL's Carbon Neutral Vision

China Carbon Neutrality Chengdu CATL Robin Zeng
CATL's Vision for Carbon Neutrality

CATL's Vision for Carbon Neutrality

China Carbon Neutrality Chengdu CATL Robin Zeng
CATL's Carbon Vision

CATL's Carbon Vision

China Carbon Neutrality Chengdu CATL Robin Zeng
Zeng's Vision for Carbon-Neutrality

Zeng's Vision for Carbon-Neutrality

China Chengdu Technology CATL Robin Zeng
CATL's Zero-Carbon Vision

CATL's Zero-Carbon Vision

China Chengdu CATL zero-carbon Robin Zeng
Robin Zeng's Carbon Neutral Vision

Robin Zeng's Carbon Neutral Vision

China Carbon Neutrality Chengdu CATL Robin Zeng
Zeng's Zero-Carbon Vision

Zeng's Zero-Carbon Vision

China Chengdu CATL zero-carbon Robin Zeng
Zeng's Vision for Zero-Carbon

Zeng's Vision for Zero-Carbon

China Chengdu zero-carbon Contemporary Amperex Robin Zeng
Hong Kong Sports Salon

Hong Kong Sports Salon

China Chengdu Hong Kong Global Connectivity E-Sports
Sports Industry Salon

Sports Industry Salon

China Chengdu Hong Kong Sports Industry
International Sports Salon

International Sports Salon

China Chengdu Hong Kong Sports Industry
Sustainability Innovation Camp

Sustainability Innovation Camp

China Belt and Road Chengdu DFRobot Unihiker Youth Maker Camp
Breakthrough Findings on CM336

Breakthrough Findings on CM336

None Chengdu Keymed Biosciences CM336 Autoimmune Hemolytic Anemia
Keymed's CM336 Results

Keymed's CM336 Results

China Chengdu Keymed Biosciences CM336 Autoimmune Hemolytic Anemia

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.